MARIA SUAREZ-ALMAZOR to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications MARIA SUAREZ-ALMAZOR has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.723
-
The updated guidelines on the use of rituximab in rheumatoid arthritis. Rheumatology (Oxford). 2011 Dec; 50(12):2153-4.
Score: 0.265
-
A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol. 2010 Sep; 29(9):947-55.
Score: 0.246
-
Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis. J Manag Care Spec Pharm. 2021 01; 27(1):73-83.
Score: 0.130
-
Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review. Arthritis Rheum. 2008 Nov 15; 59(11):1625-38.
Score: 0.056
-
Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series. Ann Rheum Dis. 2017 Dec; 76(12):2061-2064.
Score: 0.026